Ask AI
OPTIMA
OPTIMA: Phase III Noninferiority Trial of Gene Expression–Directed Chemotherapy in Patients With High-Risk ER+/HER2- Early Breast Cancer

Released: July 07, 2026

Activity

Progress
1
Course Completed
Activity Information

Released: July 07, 2026